European Medicines Agency, London, UK.
Drug Saf. 2012 Dec 1;35(12):1073-9. doi: 10.2165/11640530-000000000-00000.
Over the past decade, the annual meetings of national centres participating in the WHO Programme for International Drug Monitoring have increasingly included discussions on how to improve communication between national pharmacovigilance centres, patients, healthcare professionals, policy makers and the general public, with the aim of promoting the safe use of medicines. At the most recent meetings, working groups were dedicated to discuss possible applications and implementation of social marketing and patient-tailored approaches. This article provides the history and a summary of the recent discussions and recommendations to support progress in this respect at national and global level. Recommendations are made to investigate and pilot these approaches in small-scale projects at national pharmacovigilance centres. Applying elements from the social marketing and patient-tailored approaches to support behaviours of safe medicines use in patients and healthcare professionals should give the pharmacovigilance community new tools to achieve their goal to minimize risks with medicines and improve patient safety.
在过去的十年中，参加世界卫生组织国际药物监测规划的国家中心的年度会议越来越多地讨论如何改善国家药物警戒中心、患者、医疗保健专业人员、政策制定者和公众之间的沟通，以促进药物的安全使用。在最近的会议上，专门成立了工作组来讨论社会营销和针对患者的方法的可能应用和实施。本文提供了历史背景和最近讨论的摘要，以支持在国家和全球层面取得这方面的进展。建议在国家药物警戒中心的小规模项目中调查和试点这些方法。将社会营销和针对患者的方法的要素应用于支持患者和医疗保健专业人员安全用药行为，应为药物警戒界提供新的工具，以实现其目标，即最大限度地降低药物风险，提高患者安全性。
